Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients
Daratumumab in multiple myeloma: an overview of 3 key trials
Niels van de Donk
The Cassiopeia trial - assessing daratumumab in the context of stem cell transplantation
What are the advantages of multiple myeloma maintenance therapy?
Key studies on multiple myeloma presented at ASH 2016